News Releases

The Investor Relations website contains information about Generate Biomedicines’ business for stockholders, potential investors, and financial analysts.

News Release

Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update

View On: Generate:Biomedicines

News Release

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

View

News Release

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

View On: Generate:Biomedicines

News Release

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

View On: Generate:Biomedicines

News Release

Generate:Biomedicines Welcomes Aarif Khakoo, MD, MBA, as Chief Scientific Officer

View On: Generate:Biomedicines

News Release

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

View On: Generate:Biomedicines

News Release

Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress

View On: Generate:Biomedicines

News Release

Generate:Biomedicines Welcomes Laurie Lee, MD, as Chief Medical Officer for the Immunology & Inflammation Portfolio

View On: Generate:Biomedicines

News Release

Generate:Biomedicines Expands Board of Directors with Appointment of Marsha Fanucci

View On: Generate:Biomedicines

News Release

Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J.P. Morgan Healthcare Conference

View On: Generate:Biomedicines

Showing 1–10 of 10